BirchBioMed Inc. is a clinical-stage biomedical and commercialization-based company focused on immune system diseases, drug pipelines, and therapeutics. Founded in 2015, the privately held company maintains operations and headquarters in Ontario and Vancouver, Canada.
Subscribe to see BirchBioMed Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
BirchBioMed Inc. is a company headquartered in Canada. Its most recent funding round raised $10M in October 2025. Xcout tracks 9 named people at BirchBioMed Inc., including Mark S. Miller (Chief Executive Officer).
As of 16 November 2026. Source: Xcout Intel.
3 more named people on record for BirchBioMed Inc., with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $10M | 1 named | |
| SEC Form D filing | $2.5M | — | |
| SEC Form D filing | $596,013 | — | |
| SEC Form D filing | $398,715 | — | |
| SEC Form D filing | $10M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of BirchBioMed Inc.'s closest competitors — see the full list of competitors and alternatives →
BeBetter Med Inc. is a biotechnology company focused on developing next-generation targeted therapeutics. The company provides advanced medical treatments and pharmaceutical research solutions for patients and healthcare sectors.
ImmVue Therapeutics Inc. is a biotechnology company headquartered in Toronto, Ontario, Canada. The company operates within the biotech sector focusing on therapeutic developments.
Windward Bio is a clinical-stage biotechnology and drug development company headquartered in Basel, Switzerland. It is committed to improving outcomes for people living with serious immunological diseases through its deep discovery, development, and commercialization expertise.
OncoQuest Inc. is a private Canadian biotechnology company that focuses on immunotherapy assets and technology platforms.
Mesentech Inc. is an active for-profit biotechnology company focused on drug pipelines, therapeutic areas, and proprietary technology platforms. Headquartered in Vancouver, British Columbia, Canada, the company operates with a small team specializing in clinical research and development.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about BirchBioMed Inc.? Suggest a correction · Work at BirchBioMed Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.